Please follow https://www.fda.gov/drugs/resources-information-approved-drugs/fda-office-hematology-oncology-products-reorganizes-renamed-office-oncologic-diseases.

Please follow https://www.fda.gov/drugs/resources-information-approved-drugs/fda-office-hematology-oncology-products-reorganizes-renamed-office-oncologic-diseases.